3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
5
Unknown
1
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Postoperative Cognitive Complications
1
Pain, Postoperative
1
Pain
1
Laryngeal Neoplasms
1
Agnosia
1
Interventions
Bupivacaine
4
Analgesia
4
Ropivacaine
3
Morphine
3
Ketamine
3
Sufentanil
2
Psychiatric Rehabilitation
2
Oxycodone
2
Methadone
2
Lidocaine
2
Ketorolac
2
Hydromorphone
2
Fentanyl
2
Esketamine
2
Epinephrine
2
Docetaxel
2
Dexmedetomidine
2
Control Groups
2
Acetaminophen
2
ziconotide
1
tanezumab
1
parecoxib
1
nabiximols
1
loxoprofen
1
Whole Body Imaging
1
Vertebroplasty
1
Tramadol
1
Therapeutics
1
Telemedicine
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pain
×
Analgesics, Opioid
×
Clear all
NCT00822614
2009-01-14
FINDS
Akela Pharma, Inc.
Phase 3
Unknown
500 enrolled